TCBIO Texas Capital Bancshares, Inc. - Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B

NASDAQ · Banking · Auf SEC EDGAR ansehen ↗
$20,57
Kurs · Aug 19, 2026
Fundamentaldaten per Jul 23, 2026

Über Texas Capital Bancshares, Inc. - Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B Unternehmensübersicht von Wikipedia

Texas Capital Bank is a bank headquartered in Dallas, Texas. The bank has branches located in every major city in Texas. Its parent bank holding company is Texas Capital Bancshares. It also operates an online-only banking division, Bask Bank.

Mehr lesen

Texas Capital Bank is a bank headquartered in Dallas, Texas. The bank has branches located in every major city in Texas. Its parent bank holding company is Texas Capital Bancshares. It also operates an online-only banking division, Bask Bank.

History

The bank was established on December 18, 1998, by a group of entrepreneurial bankers who were able to raise $80 million in start-up capital, the most for a new financial institution at that time. In 2003, the company completed an IPO. The online-only subsidiary Bask Bank was launched in early 2020.

In 2020, a potential merger with Independent Bank Group of McKinney, Texas collapsed, causing the CEO to step down. In late 2021, the new CEO adopted a strategy of moving away from loan-oriented growth in the commercial banking sector, towards becoming a full-service financial institution over the following five years, and launched a new investment bank division.

On September 6, 2022, it was announced that Texas Capital Bancshares would sell BankDirect Capital Finance, a premium financing company founded in 2005, to Truist Financial for $3.4 billion. The sale was part of its strategic shift, allowing it to shed a non-core business while increasing its capital levels during the transition.

In March 2022, Texas Capital Bank was named by Newsweek Magazine as the most trustworthy bank in America, based on a survey of 50,000 U.S. residents. In October 2022, it expanded its lease at 2000 McKinney Avenue in Uptown Dallas for its headquarters, and the building was renamed Texas Capital Center. Texas Capital Bancshares received investments from several hedge funds in late 2022.

Services

The bank primarily serves clients and operates full-service locations in Austin, Dallas, Fort Worth, Houston, and San Antonio metropolitan areas of Texas. It also has an executive office in New York. As of March 2023, the company held $28.4 billion in assets and had around 2,200 employees.

The bank offers many business deposit products and services, as well as other treasury management services and consumer deposit products. The company also provides commercial loans and financing for corporate purposes, and personal wealth management and trust services. It also has an online-only banking division, Bask Bank, with perks focusing on frequent airline fliers. It operates a nonprofit arm called Texas Capital Bank Foundation.

Controversy

In Late 2020, Texas Capital Bank's stock price rose 93% on consolidation by Bill Hwang's Archegos fund. Archegos' full position amounted to a more than 20% stake in Texas Capital Bank, at its peak. During this time, Archegos was in communication with Texas Capital management about its rising stake, including with Jody Grant, who founded the Bank in 1998. Grant's discussions with Hwang's family office were friendly, and it appears Archegos were supportive of Texas Capital Bank's management.

As the stock price rose towards a two-year high around March 2021, Texas Capital decided to issue 12,000,000 new shares for an aggregate sum of $300 million. Morgan Stanley participated in leading the book building process for the offering, even as Morgan Stanley was also involved in offering Archegos' prime brokerage service and holding Texas Capital's shares for Archegos in that capacity.

In the weeks after Texas Capital's fundraising the company's market value briefly touched US$4.5 billion. Subsequently, Archegos imploded and executives of the fund were charged with fraud.

Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗

Wikidata ↗

TCBIO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs
$20.57
Marktkapitalisierung
P/E (TTM)
EPS (TTM)
Umsatz (TTM)
Dividendenrendite
ROE
Verschuldungsgrad
52W-Spanne
$20 – $23

TCBIO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis
EPS
Freier Cashflow
Margen

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl
5-Jahres-Trend
TCBIO
Peer-Median

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl
5-Jahres-Trend
TCBIO
Peer-Median

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl
5-Jahres-Trend
TCBIO
Peer-Median

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl
5-Jahres-Trend
TCBIO
Peer-Median

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl
5-Jahres-Trend
TCBIO
Peer-Median

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl
5-Jahres-Trend
TCBIO
Peer-Median

Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR

Dividendenrendite
Ausschüttungsquote
5J Div CAGR
Ex-DatumBetrag
1. Juni 2026$0,3590
2. März 2026$0,3590
1. Dezember 2025$0,3590
2. September 2025$0,3590
2. Juni 2025$0,3590
3. März 2025$0,3590
2. Dezember 2024$0,3590
3. September 2024$0,3590
3. Juni 2024$0,3590
29. Februar 2024$0,3590
30. November 2023$0,3590
31. August 2023$0,3590
31. Mai 2023$0,3590
28. Februar 2023$0,3590
30. November 2022$0,3590
31. August 2022$0,3590
31. Mai 2022$0,3590
28. Februar 2022$0,3590
30. November 2021$0,3590
31. August 2021$0,3590

TCBIO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

KAUF 19 Analysten
  • Starker Kauf 4 21,1%
  • Kauf 5 26,3%
  • Halten 8 42,1%
  • Verkauf 2 10,5%
  • Starker Verkauf 0 0,0%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung
0.16%
Zeitraum EPS Actual EPS est. Überraschung
30. Juni 2026 $1.83 $1.90 -0.07%
31. März 2026 $1.56 $1.43 0.13%
31. Dezember 2025 $2.12 $1.80 0.32%
30. September 2025 $2.18 $1.81 0.37%
30. Juni 2025 $1.58 $1.31 0.27%
31. März 2025 $0.92 $0.99 -0.07%

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
TCBIO
SFBS $3.92B 14.2 16.8% 49.2% 16.0%
TFSL $3.70B 41.2 6.0% 28.3% 4.8%
FULT
IBOC 10.0 1.0% 49.0% 13.1%
UCB $3.77B 11.9 11.7% 30.9% 9.0%
TCBI $4.69B 13.3 34.7% 26.3% 9.2%
CATY $3.25B 10.7 2.9% 585.8% 10.8%
WSFS $4.22B 10.9 27.0% 10.8%
CVBF $2.52B 12.2 2.7% 40.6% 9.2%
INDB $3.60B 16.5 24.3% 23.9% 6.2%

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Unternehmensinsider 5 Insider · 5 Führungskräfte · 0 Direktoren

Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
Rob C Holmes Chairman, President and CEO 5. Juni 2026 S 167.635 0 1 $-5.002.308
John Matthew Scurlock Chief Financial Officer 15. Juni 2026 P 22.279 1 0 $4.457
Ellen Detrich Controller 24. Juli 2026 S 7.529 0 1 $-204.561
David W Oman Chief Risk Officer 1. Juli 2026 M 3.779 0 0 $0
Anna M Alvarado Chief Legal Officer 9. Juni 2026 S 23.810 0 1 $-353.325

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

Aktivisten & 5%+-Eigentümer 1 Beteiligung

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
Sandler O’Neill Asset Management, LLC, SOAM Holdings, LLC, Malta Partners, L.P., Malta Hedge Fund, L.P., Malta Hedge Fund II, L.P., Malta Offshore, Ltd, Malta MLC Fund, LP, Malta MLC Offshore, Ltd, Malta Titan Fund, LP, SOAM Capital Partners, L.P., Terry Maltese 30. April 2009 Erste Einreichung Passive Anlage SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF-Besitz Gehalten von 2 ETFs

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
PFFD · Global X Funds 0,20% 208.923 NS 31. Mai 2026 N-PORT
GPRF · Goldman Sachs ETF Trust 0,10% 4.168 NS 31. Mai 2026 N-PORT